Skip to main content
All stocks

Nifty Healthcare Stocks List

Hospitals, diagnostics, healthcare services — pharma is in Nifty Pharma separately.

20 constituents · prices refresh daily after NSE close

Open Free Demat to Invest
Top Gainers Today
  • Laurus Labs Ltd.+5.94%
  • Fortis Healthcare Ltd.+3.25%
  • Syngene International Ltd.+2.07%
  • Cipla Ltd.+1.94%
  • Lupin Ltd.+1.89%
Top Losers Today
  • Aurobindo Pharma Ltd.-0.97%
  • Piramal Pharma Ltd.-0.97%
  • Alkem Laboratories Ltd.-0.73%
  • Glenmark Pharmaceuticals Ltd.-0.52%
  • Abbott India Ltd.-0.08%

All Nifty Healthcare constituents

20 stocks

SymbolCompanyPrice
ABBOTINDIAAbbott India Ltd.₹25,415Buy
ALKEMAlkem Laboratories Ltd.₹5,360.5Buy
APOLLOHOSPApollo Hospitals Enterprise Ltd.₹7,737.5Buy
AUROPHARMAAurobindo Pharma Ltd.₹1,376Buy
BIOCONBiocon Ltd.₹360.6Buy
CIPLACipla Ltd.₹1,335Buy
DIVISLABDivi's Laboratories Ltd.₹6,619.5Buy
DRREDDYDr. Reddy's Laboratories Ltd.Buy
FORTISFortis Healthcare Ltd.₹952.9Buy
GLENMARKGlenmark Pharmaceuticals Ltd.₹2,393.7Buy
IPCALABIpca Laboratories Ltd.₹1,530Buy
LAURUSLABSLaurus Labs Ltd.₹1,166.4Buy
LUPINLupin Ltd.₹2,348.8Buy
MANKINDMankind Pharma Ltd.₹2,257.8Buy
MAXHEALTHMax Healthcare Institute Ltd.₹1,011.55Buy
PPLPHARMAPiramal Pharma Ltd.₹160.3Buy
SUNPHARMASun Pharmaceutical Industries Ltd.₹1,823.5Buy
SYNGENESyngene International Ltd.₹477.35Buy
TORNTPHARMTorrent Pharmaceuticals Ltd.₹4,251.8Buy
ZYDUSLIFEZydus Lifesciences Ltd.₹902.35Buy

⚠️ Important Disclaimer: InvestingPro is not a registered investment advisor or SEBI-registered entity. Content is for educational purposes only and should not be considered personalized financial advice. Please consult a licensed financial professional before making investment decisions. Read full disclaimer →

Nifty Healthcareconstituents sourced from NSE's public archive. Index composition reviewed by NSE Indices Ltd quarterly. Prices are last-close values updated daily after market hours; this is not a live trading feed. Past performance is not a reliable indicator of future results.

No paid rankings
Methodology disclosed
SEBI-compliant
228+ researched articles